246 related articles for article (PubMed ID: 36869369)
1. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
[TBL] [Abstract][Full Text] [Related]
4. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
5. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
[TBL] [Abstract][Full Text] [Related]
6. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of granulosa cell tumors of the ovary.
Jamieson S; Fuller PJ
Endocr Rev; 2012 Feb; 33(1):109-44. PubMed ID: 22240241
[TBL] [Abstract][Full Text] [Related]
8. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
[TBL] [Abstract][Full Text] [Related]
9. The role of inhibins B and antimüllerian hormone for diagnosis and follow-up of granulosa cell tumors.
Geerts I; Vergote I; Neven P; Billen J
Int J Gynecol Cancer; 2009 Jul; 19(5):847-55. PubMed ID: 19574772
[TBL] [Abstract][Full Text] [Related]
10. [Study on the anti-müllerian hormone served as a marker for granulosa cell tumor of ovary].
Long W; Wang W; Rey R
Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):356-8. PubMed ID: 11776178
[TBL] [Abstract][Full Text] [Related]
11. A clinicopathological study of granulosa cell tumors of the ovary: Can morphology predict prognosis?
Guleria P; Kumar L; Kumar S; Bhatla N; Ray R; Singhal S; Meena J; Mathur SR
Indian J Pathol Microbiol; 2020; 63(1):53-59. PubMed ID: 32031123
[TBL] [Abstract][Full Text] [Related]
12. [Recurrence occurring ten years after the initial diagnosis of granulosa cell tumour of the ovary: about two cases and review of the literatur].
Majdoul S; Tawfiq N; Bourhaleb Z; Naqos N; Taleb A; Bouchbika Z; Benchakroun N; Jouhadi H; Sahraoui S; Benider A
Pan Afr Med J; 2016; 25():30. PubMed ID: 28154722
[TBL] [Abstract][Full Text] [Related]
13. Progress in the management of ovarian granulosa cell tumor: A review.
Li J; Chu R; Chen Z; Meng J; Yao S; Song K; Kong B
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1771-1778. PubMed ID: 34027996
[TBL] [Abstract][Full Text] [Related]
14. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
[TBL] [Abstract][Full Text] [Related]
16. The value of the prognostic factors in ovarian granulosa cell tumors.
Wabersich J; Fracas M; Mazzer S; Marchetti M; Altavilla G
Eur J Gynaecol Oncol; 1998; 19(1):69-72. PubMed ID: 9476064
[TBL] [Abstract][Full Text] [Related]
17. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
18. Ovarian granulosa cell tumors in childhood.
Merras-Salmio L; Vettenranta K; Möttönen M; Heikinheimo M
Pediatr Hematol Oncol; 2002; 19(3):145-56. PubMed ID: 11936727
[TBL] [Abstract][Full Text] [Related]
19. Secondary Amenorrhea and Infertility Due to an Inhibin B Producing Granulosa Cell Tumor of the Ovary. A Rare Case Report and Literature Review.
Gică C; Cigăran RG; Botezatu R; Panaitescu AM; Cimpoca B; Peltecu G; Gică N
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441035
[TBL] [Abstract][Full Text] [Related]
20. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
